AMANDA WHITMAN: Open Payments
NPI 1700611894 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 83 payments from 30 companies in 2025. Trend: 2023 $0 · 2024 $313 · 2025 $1,953
Food & beverage: $1,953
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 2 | $234 |
| Lundbeck LLC | 10 | $178 |
| Lilly USA, LLC | 7 | $157 |
| Aucta Pharmaceuticals, Inc. | 9 | $135 |
| Corcept Therapeutics | 6 | $135 |
| Neurelis, Inc. | 6 | $112 |
| Neurocrine BioSciences, Inc. | 5 | $103 |
| Alexion Pharmaceuticals, Inc. | 4 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $97 |
| BETA BIONICS, INC. | 2 | $89 |
Products named: TWIIST, VYEPTI, Motpoly XR, Korlym, VALTOCO, INGREZZA, ULTOMIRIS, iLet Bionic Pancreas.
Industry payments across NC — which companies pay providers there.
